We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toDigital-Data-Flow-from-Protocol-to-Report-TransCelerate-s-Common-Protocol-Template-and-the-Art-of-the-Possible

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.


Digital Data Flow from Protocol to Report: TransCelerate’s Common Protocol Template and the Art of the Possible

    Session Chair(s)
      Robert A. DiCicco, PharmD

      Robert A. DiCicco, PharmD

      • Executive Consultant
      • TransCelerate Biopharma Inc., United States
    TransCelerate BioPharma common protocol template (CPT) was first released in December 2015. It was updated in 2017 based on collaboration with NIH-FDA to align templates from both organizations. Since the initial release CPT has been downloaded over 3,700 times by several hundred unique clinical research organizations including Pharma, CROs, academic institutions and health authorities. In 2016 the project initiated proof of concept programs, using the technology enhanced CPT, with the aim of demonstrating automated reuse of protocol information for critical activities such as eCRF generation and registry posting. The session will focus on the development of prototypes which deliver high value applications of a machine readable protocol. In addition, a model which describes traceability from protocol to report will be described. Current applications of the technology enabled edition of the CPT will also be presented.
    Learning Objective : Discuss the benefits of digital data flow, including accelerating time to study start up; Describe how the technology enabled edition of the CPT delivers automated traceability; Discuss future opportunities for implementation.
    Speaker(s)
      Richard  Buckley, JD, MBA

      Panelist

      Richard Buckley, JD, MBA

      • Clinical Innovation, TransCelerate Program Lead, Operations Center of Excellence
      • Pfizer Inc, United States
      Jeff  Beeler

      Panelist

      Jeff Beeler

      • Vice President, Product Innovation, eClinical, Clinical Development
      • IBM Watson Health, United States
      Michel  Rider, DrMed

      Panelist

      Michel Rider, DrMed

      • Managing Director, Life Sciences Cloud Strategy
      • Accenture, United States